Recent evidence suggests that markers such as interleukin-6 (IL-6) and pentraxin-3 (PTX-3) are elevated in patients with obstructive sleep apnea (OSA), even in the absence of hypertension. Here, PTX3 is linked to obstructive sleep apnea syndrome.